Notice of Registration - 2012
[Federal Register Volume 77, Number 54 (Tuesday, March 20, 2012)]
[Notices]
[Page 16264]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-6703]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances, Notice of Registration;
Johnson Matthey Pharmaceutical Materials Inc.
By Notice dated November 18, 2011, and published in the Federal
Register on November 28, 2011, 76 FR 72974, Johnson Matthey
Pharmaceutical Materials Inc., Pharmaceutical Service, 25 Patton Road,
Devens, Massachusetts 01434, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
| Drug |
Schedule |
| Amphetamine (1100) |
II |
| Methylphenidate (1724) |
II |
| Nabilone (7379) |
II |
| Hydrocodone (9193) |
II |
| Alfentanil (9737) |
II |
| Remifentanil (9739) |
II |
| Sufentanil (9740) |
II |
The company plans to utilize this facility to manufacture small
quantities of the listed controlled substances in bulk and to conduct
analytical testing in support of the company's primary manufacturing
facility in West Deptford, New Jersey. The controlled substances
manufactured in bulk at this facility will be distributed to the
company's customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a), and determined that the registration
of Johnson Matthey Pharmaceutical Materials Inc. to manufacture the
listed basic classes of controlled substances is consistent with the
public interest at this time. DEA has investigated Johnson Matthey
Pharmaceutical Materials Inc. to ensure that the company's registration
is consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above
named company is granted registration as a bulk manufacturer of the
basic classes of controlled substances listed.
Dated: March 8, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-6703 Filed 3-19-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
